The protective effect of umbelliferone ameliorates myocardial injury following ischemia‑reperfusion in the rat through suppression NLRP3 inflammasome and upregulating the PPAR-γ

Luo,Hongbo; Fan,Zhengke; Xiang,Daokang; Jiang,Zhenwei; Zhang,Wenbin; Gao,Lufang; Feng,Chao

doi:10.3892/mmr.2017.8208

The protective effect of umbelliferone ameliorates myocardial injury following ischemia‑reperfusion in the rat through suppression NLRP3 inflammasome and upregulating the PPAR-γ

Authors:
- Hongbo Luo
- Zhengke Fan
- Daokang Xiang
- Zhenwei Jiang
- Wenbin Zhang
- Lufang Gao
- Chao Feng
View Affiliations

Affiliations: Department of Cardiovascular Surgery, The People's Hospital of Guizhou, Guiyang, Guizhou 550002, P.R. China, Department of Cardiothoracic Surgery, The First People's Hospital, Bijie, Guizhou 551700, P.R. China
Published online on: December 6, 2017 https://doi.org/10.3892/mmr.2017.8208
Pages: 3404-3410

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated whether the protective effect of umbelliferone could regulate myocardial injury following ischemia‑reperfusion and improve mitochondrial respiratory function, thereby relieving myocardial injury following ischemia‑reperfusion in rats. In the present study, the extent of inflammation and oxidative stress were analyzed using ELISA. Western blot analysis was employed to investigate the protein expression levels of the PYD domains‑containing protein 3 (NLRP3) inflammasome and peroxisome proliferator‑activated receptor-γ (PPAR‑γ). Compared with the myocardial injury following ischemia‑reperfusion group, umbelliferone significantly prevented myocardial injury, inhibited oxidative stress markers (superoxide dismutase and malondialdehyde), reduced inflammation (tumor necrosis factor‑α and interleukin‑6) and myocardial apoptosis levels (caspase‑3/9 and apoptosis regular B‑cell lymphoma‑2‑associated X protein) in the myocardial injury following ischemia‑reperfusion group of rats. Umbelliferone treatment also suppressed NACHT, LRR and NLRP3 inflammasome activation and induced PPAR‑γ expression. The results of the present study suggested that the protective effect of umbelliferone may ameliorate myocardial injury following ischemia‑reperfusion in the rat through the suppression of the NLRP3 inflammasome and upregulating PPAR‑γ expression.

View Figures

View References

1	Prasad A, Gersh BJ, Mehran R, Brodie BR, Brener SJ, Dizon JM, Lansky AJ, Witzenbichler B, Kornowski R, Guagliumi G, et al: Effect of ischemia duration and door-to-balloon time on myocardial perfusion in ST-segment elevation myocardial infarction: An analysis from HORIZONS-AMI trial (harmonizing outcomes with revascularization and stents in acute myocardial infarction). JACC Cardiovasc Interv. 8:1966–1974. 2015. View Article : Google Scholar : PubMed/NCBI
2	Grygier M, Araszkiewicz A, Lesiak M, Janus M, Kowal J, Skorupski W, Pyda M, Mitkowski P and Grajek S: New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol. 107:1131–1135. 2011. View Article : Google Scholar : PubMed/NCBI
3	Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ and Kim KS: Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary interventio: Results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol. 33:2252–2260. 2013. View Article : Google Scholar : PubMed/NCBI
4	Hamarneh A, Sivaraman V, Bulluck H, Shanahan H, Kyle B, Ramlall M, Chung R, Jarvis C, Xenou M, Ariti C, et al: The effect of remote ischemic conditioning and glyceryl trinitrate on perioperative myocardial injury in cardiac bypass surgery patients: Rationale and design of the ERIC-GTN study. Clin Cardiol. 38:641–646. 2015. View Article : Google Scholar : PubMed/NCBI
5	Toldo S, Marchetti C, Mauro AG, Chojnacki J, Mezzaroma E, Carbone S, Zhang S, Van Tassell B, Salloum FN and Abbate A: Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse. Int J Cardiol. 209:215–220. 2016. View Article : Google Scholar : PubMed/NCBI
6	Yu SY, Tang L, Zhao GJ and Zhou SH: Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome. Int J Cardiol. 229:23–24. 2017. View Article : Google Scholar : PubMed/NCBI
7	Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, He J, Kim E, Filippone S, Das A, Toldo S, Abbate A and Salloum FN: Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism. Cardiovasc Res. 113:609–619. 2017.PubMed/NCBI
8	Wu Y, Tan X, Tian J, Liu X, Wang Y, Zhao H, Yan Z, Liu H and Ma X: PPARγ agonist ameliorates the impaired fluidity of the myocardial cell membrane and cardiac injury in hypercholesterolemic rats. Cardiovasc Toxicol. 17:25–34. 2017. View Article : Google Scholar : PubMed/NCBI
9	Ravingerova T, Adameova A, Carnicka S, Nemcekova M, Kelly T, Matejikova J, Galatou E, Barlaka E and Lazou A: The role of PPAR in myocardial response to ischemia in normal and diseased heart. Gen Physiol Biophys. 30:329–341. 2011. View Article : Google Scholar : PubMed/NCBI
10	Rezaee R, Behravan E, Behravan J, Soltani F, Naderi Y, Emami B and Iranshahi M: Antigenotoxic activities of the natural dietary coumarins umbelliferone, herniarin and 7-isopentenyloxy coumarin on human lymphocytes exposed to oxidative stress. Drug Chem Toxicol. 37:144–148. 2014. View Article : Google Scholar : PubMed/NCBI
11	Chunhua M, Lingdong K, Hongyan L and Zhangqiang M: Retracted: Umbelliferone reverses depression-like behavior in chronic unpredictable mild stress-induced mice via RIP140/NF-κB pathway. IUBMB Life. 69:7672017. View Article : Google Scholar
12	Vijayalakshmi A and Sindhu G: Dose responsive efficacy of umbelliferone on lipid peroxidation, anti-oxidant, and xenobiotic metabolism in DMBA-induced oral carcinogenesis. Biomed Pharmacother. 88:852–862. 2017. View Article : Google Scholar : PubMed/NCBI
13	Hofsten DE, Kelbaek H, Helqvist S, Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH, Bøtker HE, Jensen LO, et al: The third DANish study of optimal acute treatment of patients with ST-segment elevation myocardial infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program. Am Heart J. 169:613–621. 2015. View Article : Google Scholar : PubMed/NCBI
14	Hausenloy DJ, Candilio L, Laing C, Kunst G, Pepper J, Kolvekar S, Evans R, Robertson S, Knight R, Ariti C, et al: Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): Rationale and study design of a multi-centre randomized double-blinded controlled clinical trial. Clin Res Cardiol. 101:339–348. 2012. View Article : Google Scholar : PubMed/NCBI
15	Gu YL, Kampinga MA, Wieringa WG, Fokkema ML, Nijsten MW, Hillege HL, Van den Heuvel AF, Tan ES, Pundziute G, van der Werf R, et al: Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: The comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial. Circulation. 122:2709–2717. 2010. View Article : Google Scholar : PubMed/NCBI
16	Pei H, Song X, Peng C, Tan Y, Li Y, Li X, Ma S, Wang Q, Huang R, Yang D, et al: TNF-α inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress. Free Radic Biol Med. 82:114–121. 2015. View Article : Google Scholar : PubMed/NCBI
17	Yue R, Xia X, Jiang J, Yang D, Han Y, Chen X, Cai Y, Li L, Wang WE and Zeng C: Mitochondrial DNA oxidative damage contributes to cardiomyocyte ischemia/reperfusion-injury in rats: Cardioprotective role of lycopene. J Cell Physiol. 230:2128–2141. 2015. View Article : Google Scholar : PubMed/NCBI
18	Yu Z, Wang S, Zhang X, Li Y, Zhao Q and Liu T: Pterostilbene protects against myocardial ischemia/reperfusion injury via suppressing oxidative/nitrative stress and inflammatory response. Int Immunopharmacol. 43:7–15. 2017. View Article : Google Scholar : PubMed/NCBI
19	Zheng P, Xie Z, Yuan Y, Sui W, Wang C, Gao X, Zhao Y, Zhang F, Gu Y, Hu P, et al: Plin5 alleviates myocardial ischaemia/reperfusion injury by reducing oxidative stress through inhibiting the lipolysis of lipid droplets. Sci Rep. 7:425742017. View Article : Google Scholar : PubMed/NCBI
20	Zhang J, Zhang J, Yu P, Chen M, Peng Q, Wang Z and Dong N: Remote ischaemic preconditioning and sevoflurane postconditioning synergistically protect rats from myocardial injury induced by ischemia and reperfusion partly via Inhibition TLR4/MyD88/NF-κB signaling pathway. Cell Physiol Biochem. 41:22–32. 2017. View Article : Google Scholar : PubMed/NCBI
21	Sandanger Ø, Ranheim T, Vinge LE, Bliksøen M, Valen G, Aukrust P and Yndestad A: A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Reply. Cardiovasc Res. 99:226–227. 2013. View Article : Google Scholar : PubMed/NCBI
22	Sandanger Ø, Ranheim T, Vinge LE, Bliksøen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, et al: The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res. 99:164–174. 2013. View Article : Google Scholar : PubMed/NCBI
23	Wang X, Li R, Wang X, Fu Q and Ma S: Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome. Neurosci Lett. 600:182–187. 2015. View Article : Google Scholar : PubMed/NCBI
24	Liu X, Yu Z, Huang X, Gao Y, Wang X, Gu J and Xue S: Peroxisome proliferator-activated receptor γ (PPARγ) mediates the protective effect of quercetin against myocardial ischemia-reperfusion injury via suppressing the NF-κB pathway. Am J Transl Res. 8:5169–5186. 2016.PubMed/NCBI
25	Qian J, Chen H, Birnbaum Y, Nanhwan MK, Bajaj M and Ye Y: Aleglitazar, a balanced dual PPARα and -γ agonist, protects the heart against ischemia-reperfusion injury. Cardiovasc Drugs Ther. 30:129–141. 2016. View Article : Google Scholar : PubMed/NCBI
26	Mahmoud AM, Germoush MO, Alotaibi MF and Hussein OE: Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother. 86:297–306. 2017. View Article : Google Scholar : PubMed/NCBI